Tom Anderson, SwanBio Therapeutics CEO

Scoop: Af­ter fail­ing to se­cure more funds, a pri­vate gene ther­a­py de­vel­op­er lays off staff

Last Fri­day, Swan­Bio Ther­a­peu­tics laid off about one-quar­ter of its 60-per­son work­force, a per­son with knowl­edge of the mat­ter told End­points News.

The gene ther­a­py …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.